DKI Health embarked on a mission to understand the perspectives of patients prescribed antibiotics for COVID-19. By actively engaging with patients and highlighting their experiences, we provided invaluable insights to the medical community.

This publication exemplifies DKI Health's commitment to empowering patients and integrating their voices systematically into research and publications.

DKI Health published a call to action targeted at industry executives and policy decision-makers.

This publication highlights the urgent need for developing innovative antibiotics as a crucial measure to combat antimicrobial resistance (AMR).

DKI Health collaborated with Pfizer-BMS Alliance colleagues and Key Opinion Leaders to identify screening and diagnosis gaps in atrial fibrillation (AF) and devise strategies to mitigate the risk of AF-related stroke prevention.

Our extensive research spanning several years culminated in a notable publication in EU Politico in 2020.